Inozyme Pharma shares owned by Morgan Stanley
Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Inozyme Pharma
Tip: Access up to 7 years of quarterly data
All positions including Inozyme Pharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inozyme Pharma by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $499k | 125k | 4.00 |
| 2024-12-31 | $409k | 148k | 2.77 |
| 2024-09-30 | $831k | 159k | 5.23 |
| 2024-06-30 | $352k | 79k | 4.46 |
| 2024-03-31 | $952k | 124k | 7.66 |
| 2023-12-31 | $492k | 116k | 4.26 |
| 2023-09-30 | $111k | 26k | 4.20 |
| 2023-06-30 | $187k | 34k | 5.57 |
| 2022-12-31 | $14k | 13k | 1.03 |
| 2022-06-30 | $217k | 41k | 5.26 |
| 2022-03-31 | $65k | 16k | 4.07 |
| 2021-06-30 | $688k | 43k | 16.09 |
| 2020-12-31 | $406k | 20k | 20.64 |
| 2020-09-30 | $33k | 1.3k | 26.38 |